Business Equipment & Supplies
Compare Stocks
2 / 10Stock Comparison
ACCL vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
ACCL vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Business Equipment & Supplies | Medical - Care Facilities |
| Market Cap | $21M | $10.18B |
| Revenue (TTM) | $559K | $5.27B |
| Net Income (TTM) | $127K | $363M |
| Gross Margin | 48.5% | 15.2% |
| Operating Margin | 24.2% | 8.5% |
| Forward P/E | 162.6x | 23.2x |
| Total Debt | $11K | $4.15B |
| Cash & Equiv. | $261K | $504M |
Quick Verdict: ACCL vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ACCL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.78, Low D/E 7.2%, current ratio 1.71x
- 22.7% margin vs ENSG's 6.9%
- 31.5% ROA vs ENSG's 6.8%
ENSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 7.5% 10Y total return vs ACCL's -63.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs ACCL's 18.2% | |
| Value | Lower P/E (23.2x vs 162.6x) | |
| Quality / Margins | 22.7% margin vs ENSG's 6.9% | |
| Stability / Safety | Beta 0.42 vs ACCL's 0.78 | |
| Dividends | 0.1% yield, 12-year raise streak, vs ACCL's 0.0% | |
| Momentum (1Y) | +27.5% vs ACCL's -63.5% | |
| Efficiency (ROA) | 31.5% ROA vs ENSG's 6.8% |
ACCL vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ACCL vs ENSG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ACCL leads this category, winning 4 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 9439.9x ACCL's $558,690. ACCL is the more profitable business, keeping 22.7% of every revenue dollar as net income compared to ENSG's 6.9%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $558,690 | $5.3B |
| EBITDAEarnings before interest/tax | — | $558M |
| Net IncomeAfter-tax profit | — | $363M |
| Free Cash FlowCash after capex | — | $406M |
| Gross MarginGross profit ÷ Revenue | +48.5% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +24.2% | +8.5% |
| Net MarginNet income ÷ Revenue | +22.7% | +6.9% |
| FCF MarginFCF ÷ Revenue | +25.7% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +21.9% |
Valuation Metrics
ENSG leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 29.8x trailing earnings, ENSG trades at a 82% valuation discount to ACCL's 162.6x P/E. On an enterprise value basis, ENSG's 25.7x EV/EBITDA is more attractive than ACCL's 137.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $21M | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $20M | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | 162.64x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.16x |
| EV / EBITDAEnterprise value multiple | 137.28x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 36.95x | 2.01x |
| Price / BookPrice ÷ Book value/share | 139.85x | 4.59x |
| Price / FCFMarket cap ÷ FCF | 143.72x | 27.46x |
Profitability & Efficiency
ACCL leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
ACCL delivers a 61.0% return on equity — every $100 of shareholder capital generates $61 in annual profit, vs $17 for ENSG. ACCL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), ACCL scores 8/9 vs ENSG's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +61.0% | +16.6% |
| ROA (TTM)Return on assets | +31.5% | +6.8% |
| ROICReturn on invested capital | — | +7.0% |
| ROCEReturn on capital employed | +63.8% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.07x | 1.86x |
| Net DebtTotal debt minus cash | -$250,501 | $3.7B |
| Cash & Equiv.Liquid assets | $261,091 | $504M |
| Total DebtShort + long-term debt | $10,590 | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | — | 88.33x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $3,654 for ACCL. Over the past 12 months, ENSG leads with a +27.5% total return vs ACCL's -63.5%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs ACCL's -28.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -46.4% | +0.3% |
| 1-Year ReturnPast 12 months | -63.5% | +27.5% |
| 3-Year ReturnCumulative with dividends | -63.5% | +88.9% |
| 5-Year ReturnCumulative with dividends | -63.5% | +103.2% |
| 10-Year ReturnCumulative with dividends | -63.5% | +752.0% |
| CAGR (3Y)Annualised 3-year return | -28.5% | +23.6% |
Risk & Volatility
ENSG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than ACCL's 0.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ENSG currently trades 80.0% from its 52-week high vs ACCL's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 0.42x |
| 52-Week HighHighest price in past year | $5.00 | $218.00 |
| 52-Week LowLowest price in past year | $1.23 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +29.6% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 50.2 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 49K | 358K |
Analyst Outlook
ENSG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $222.33 |
| # AnalystsCovering analysts | — | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.0% | +0.1% |
| Dividend StreakConsecutive years of raises | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.00 | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% |
ENSG leads in 4 of 6 categories (Valuation Metrics, Total Returns). ACCL leads in 2 (Income & Cash Flow, Profitability & Efficiency).
ACCL vs ENSG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ACCL or ENSG a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 18. 2% for Acco Group Holdings Limited Ordinary Shares (ACCL). The Ensign Group, Inc. (ENSG) offers the better valuation at 29. 8x trailing P/E (23. 2x forward), making it the more compelling value choice. Analysts rate The Ensign Group, Inc. (ENSG) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ACCL or ENSG?
On trailing P/E, The Ensign Group, Inc.
(ENSG) is the cheapest at 29. 8x versus Acco Group Holdings Limited Ordinary Shares at 162. 6x.
03Which is the better long-term investment — ACCL or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -63. 5% for Acco Group Holdings Limited Ordinary Shares (ACCL). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACCL's -63. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ACCL or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Acco Group Holdings Limited Ordinary Shares's 0. 78β — meaning ACCL is approximately 86% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Acco Group Holdings Limited Ordinary Shares (ACCL) carries a lower debt/equity ratio of 7% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ACCL or ENSG?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus 18. 2% for Acco Group Holdings Limited Ordinary Shares (ACCL). Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ACCL or ENSG?
Acco Group Holdings Limited Ordinary Shares (ACCL) is the more profitable company, earning 22.
7% net margin versus 6. 8% for The Ensign Group, Inc. — meaning it keeps 22. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACCL leads at 24. 2% versus 8. 6% for ENSG. At the gross margin level — before operating expenses — ACCL leads at 48. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — ACCL or ENSG?
In this comparison, ENSG (0.
1% yield) pays a dividend. ACCL does not pay a meaningful dividend and should not be held primarily for income.
08Is ACCL or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, ACCL: -63. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ACCL and ENSG?
These companies operate in different sectors (ACCL (Industrials) and ENSG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.